Head Corporate Development
- An accomplished senior-level executive with over 30 years of experience and successful track records in the life sciences industry.
- Worked as Chief Business Officer for Inomagen Therapeutics and Salarius Pharmaceuticals.
- Secured $2.6M in capital from an Equity Line sponsored by Aspire Capital for Salarius Pharmaceuticals and closed a $48M Reverse Merger with Flex Pharma listing the company on NASDAQ in 2019.
- BA in Marketing from Michigan State University and an MBA from the Kellstadt Graduate School of Business at DePaul University.